Related Experiment Video
Updated: Aug 13, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
When the lungs are involved by connective tissue disease
B Mukerji1, M A Alpert, J G Hardin
1University of South Alabama College of Medicine, Mobile.
Postgraduate Medicine
|October 1, 1993
Summary
Connective tissue diseases can cause serious lung complications through various mechanisms. Early diagnosis and treatment of these pulmonary issues are crucial for improving patient outcomes and prognosis.
Area of Science:
- Rheumatology
- Pulmonology
- Immunology
Background:
- Connective tissue diseases (CTDs) frequently involve the lungs, leading to significant morbidity.
- Pulmonary complications arise from diverse pathogenic mechanisms, including granulomatous reactions, interstitial inflammation, vasculitis, and immune complex deposition.
- Diagnosing lung involvement in CTDs is complex due to overlapping patterns of disease and shared radiological findings.
Purpose of the Study:
- To elucidate the varied pathogenic mechanisms underlying pulmonary complications in connective tissue diseases.
- To highlight the diagnostic challenges posed by the heterogeneity of lung involvement patterns in CTDs.
- To emphasize the importance of early recognition and prompt treatment for improving patient prognosis.
Main Methods:
- Review of existing literature on pulmonary manifestations of connective tissue diseases.
- Analysis of pathogenic pathways involved in CTD-related lung disease.
- Correlation of clinical presentation with histopathological findings.
Main Results:
- Pulmonary involvement in CTDs presents with diverse pathological findings, including interstitial lung disease, pulmonary arterial hypertension, and airway disease.
- Multiple CTDs can manifest with similar lung abnormalities, complicating differential diagnosis.
- Specific CTDs are associated with distinct, yet sometimes overlapping, patterns of lung injury.
Conclusions:
- Pulmonary complications are a critical aspect of connective tissue disease management.
- Understanding the diverse mechanisms and presentations of lung involvement is key for accurate diagnosis.
- Timely intervention in CTD-related pulmonary disease significantly impacts patient prognosis and survival.
Related Concept Videos
01:13Pleura of the Lungs
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...